Terms: = Prostate cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Treatment
293 results:
1. A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients.
Lilly MB; Wu C; Ke Y; Chen WP; Soloff AC; Armeson K; Yokoyama NN; Li X; Song L; Yuan Y; McLaren CE; Zi X
Clin Transl Med; 2024 Mar; 14(3):e1627. PubMed ID: 38515274
[TBL] [Abstract] [Full Text] [Related]
2. Strong Correlation Between SUV
Berrens AC; Sorbi MA; Donswijk ML; de Barros HA; Azargoshasb S; van Oosterom MN; Rietbergen DDD; Bekers EM; van der Poel HG; van Leeuwen FWB; van Leeuwen PJ
J Nucl Med; 2024 Apr; 65(4):548-554. PubMed ID: 38485277
[TBL] [Abstract] [Full Text] [Related]
3. Discovery of CBPD-268 as an Exceptionally Potent and Orally Efficacious CBP/p300 PROTAC Degrader Capable of Achieving Tumor Regression.
Chen Z; Wang M; Wu D; Bai L; Xu T; Metwally H; Wang Y; McEachern D; Zhao L; Li R; Takyi-Williams J; Wang M; Wang L; Li Q; Wen B; Sun D; Wang S
J Med Chem; 2024 Apr; 67(7):5275-5304. PubMed ID: 38477974
[TBL] [Abstract] [Full Text] [Related]
4. Demonstrating Bioequivalence for Two Dose Strengths of Niraparib and Abiraterone Acetate Dual-Action Tablets Versus Single Agents: Utility of Clinical Study Data Supplemented with Modeling and Simulation.
Yu A; Hazra A; Jiao JJ; Hellemans P; Mitselos A; Tian H; Ruixo JJP; Haddish-Berhane N; Ouellet D; Russu A
Clin Pharmacokinet; 2024 Apr; 63(4):511-527. PubMed ID: 38436924
[TBL] [Abstract] [Full Text] [Related]
5. Bony lesion analysis in carcinoma prostate: methylene diphosphonate bone scan vs. Gallium-68 psma-11 pet/ct.
Ali H; Rashid Ul Amin S; Hai A; Nizar N
J Ayub Med Coll Abbottabad; 2023; 35(3):415-418. PubMed ID: 38404083
[TBL] [Abstract] [Full Text] [Related]
6. The association between age and long-term quality of life after curative treatment for prostate cancer: a cross-sectional study.
Sletten R; Berger Christiansen O; Oldervoll LM; Åstrøm L; Kjesbu Skjellegrind H; Šaltytė Benth J; Kirkevold Ø; Bergh S; Grønberg BH; Rostoft S; Bye A; Mork PJ; Slaaen M
Scand J Urol; 2024 Feb; 59():31-38. PubMed ID: 38379397
[TBL] [Abstract] [Full Text] [Related]
7. Metastatic castration resistant prostate cancer patients' experience with Radium-223 treatment in Japan.
Akakura K; Uemura H; Kawakami S; Yokomizo A; Nakamura M; Nishimura K; Komori T; Ledesma DA
Future Oncol; 2024 Apr; 20(12):781-798. PubMed ID: 38275149
[TBL] [Abstract] [Full Text] [Related]
8. PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting Prognosis.
Xiong M; Chen Z; Zhou C; Yang X; Hu W; Jiang Y; Zheng R; Fan W; Mou Y; Lin X
Recent Pat Anticancer Drug Discov; 2024; 19(3):383-395. PubMed ID: 38214322
[TBL] [Abstract] [Full Text] [Related]
9. Bioequivalence, food effect and comparative pharmacokinetics of SUVN-1105, a novel granule formulation of abiraterone acetate, to Zytiga in healthy male subjects.
Nirogi R; Ravula J; Benade V; Goyal VK; Pandey SK; Dogiparti D; Jayarajan P; Kalaikadhiban I; Jetta S; Palacharla VRC
Cancer Chemother Pharmacol; 2024 Mar; 93(3):253-264. PubMed ID: 38157042
[TBL] [Abstract] [Full Text] [Related]
10. Mechanisms Behind the Pharmacological Application of Biochanin-A: A review.
Anuranjana PV; Beegum F; K P D; George KT; Viswanatha GL; Nayak PG; Kanwal A; Kishore A; Shenoy RR; Nandakumar K
F1000Res; 2023; 12():107. PubMed ID: 38106650
[TBL] [Abstract] [Full Text] [Related]
11. Dosimetric predictors for genitourinary toxicity in MR-guided stereotactic body radiation therapy (SBRT): Substructure with fraction-wise analysis.
Pham J; Neilsen BK; Liu H; Cao M; Yang Y; Sheng K; Ma TM; Kishan AU; Ruan D
Med Phys; 2024 Jan; 51(1):612-621. PubMed ID: 38055353
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of Multiple Segmentation Methods for Volumetric Delineation of Primary prostate cancer with prostate-Specific Membrane Antigen-Targeted
Wang F; Liu C; Vidal I; Mana-Ay M; Voter AF; Solnes LB; Ross AE; Gafita A; Schaeffer EM; Bivalacqua TJ; Pienta KJ; Pomper MG; Lodge MA; Song DY; Oldan JD; Allaf ME; De Marzo AM; Sheikhbahaei S; Gorin MA; Rowe SP
J Nucl Med; 2024 Jan; 65(1):87-93. PubMed ID: 38050147
[TBL] [Abstract] [Full Text] [Related]
13. Multi-planner validation of RapidPlan knowledge-based model for volumetric modulated arc therapy in prostate cancer.
Ayuthaya IIN; Sanghangthum T; Oonsiri P; Oonsiri S; Keawsamur M; Ruangchan S; Vannavijit C; Kanphet J; Kingkaew S; Vimolnoch M; Tawonwong T; Plangpleng N
J Appl Clin Med Phys; 2024 Jan; 25(1):e14223. PubMed ID: 38009569
[TBL] [Abstract] [Full Text] [Related]
14. Advancing knowledge-based intensity modulated proton planning for adaptive treatment of high-risk prostate cancer.
Johnson CL; Hasan S; Huang S; Lin H; Gorovets D; Shim A; Apgar T; Yu F; Tsai P
Med Dosim; 2024 Spring; 49(1):19-24. PubMed ID: 37914563
[TBL] [Abstract] [Full Text] [Related]
15. 68 Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters.
Verma P; Singh BK; Sudhan MD; Singh RK; Bagul SD; Chandak AR; Soni BK; Shelly D; Basu S
Clin Nucl Med; 2023 Dec; 48(12):e559-e563. PubMed ID: 37883060
[TBL] [Abstract] [Full Text] [Related]
16. Impact of Interfractional Bladder and Trigone Displacement and Deformation on Radiation Exposure and Subsequent Acute Genitourinary Toxicity: A Post Hoc Analysis of Patients Treated with Magnetic Resonance Imaging-Guided prostate Stereotactic Body Radiation Therapy in a Phase 3 Randomized Trial.
Neilsen BK; Ma TM; Akingbemi WO; Neylon J; Casado MC; Sharma S; Sheng K; Ruan D; Low DA; Yang Y; Valle LF; Steinberg ML; Lamb JM; Cao M; Kishan AU
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(4):986-997. PubMed ID: 37871887
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic Performance of PSMA-Based 18 F-DCFPyL PET/CT in prostate cancer Patients After Definitive treatment With PSA Level ≤0.2 ng/mL.
Lu Y; Wilson ZJ; Xu G; Xu Z; Pan T; Wei P
Clin Nucl Med; 2023 Dec; 48(12):1021-1027. PubMed ID: 37801580
[TBL] [Abstract] [Full Text] [Related]
18. Comparison of parametric imaging and SUV imaging with [
Chen R; Ng YL; Yang X; Zhu Y; Li L; Zhao H; Zhou Y; Huang G; Liu J
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):568-580. PubMed ID: 37792025
[TBL] [Abstract] [Full Text] [Related]
19.
Ma XK; Liu TL; Ren YN; Ma XP; Yao Y; Hou XG; Ding J; Wang F; Huang HF; Zhu H; Yang Z
Acta Pharmacol Sin; 2024 Feb; 45(2):436-448. PubMed ID: 37749238
[TBL] [Abstract] [Full Text] [Related]
20. Benefits of Soybean in the Era of Precision Medicine: A Review of Clinical Evidence.
Kang JH; Dong Z; Shin SH
J Microbiol Biotechnol; 2023 Dec; 33(12):1552-1562. PubMed ID: 37674385
[TBL] [Abstract] [Full Text] [Related]
[Next]
